Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments

Gliomas are one of the most lethal types of cancers accounting for ∼80% of all central nervous system (CNS) primary malignancies. Among gliomas, glioblastomas (GBM) are the most aggressive, characterized by a median patient survival of fewer than 15  months. Recent molecular characterization studies...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Pharmacol
Autori principali: Alghamri, Mahmoud S., McClellan, Brandon L., Hartlage, Carson S., Haase, Santiago, Faisal, Syed Mohd, Thalla, Rohit, Dabaja, Ali, Banerjee, Kaushik, Carney, Stephen V., Mujeeb, Anzar A., Olin, Michael R., Moon, James J., Schwendeman, Anna, Lowenstein, Pedro R., Castro, Maria G.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2021
Soggetti:
Pharmacology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8167057/
https://ncbi.nlm.nih.gov/pubmed/34084145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.680021
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi